Wolverine Asset Management »

Mirum Pharmaceuticals shares owned by Wolverine Asset Management

Quarter-by-quarter ownership of Mirum Pharmaceuticals (MIRM) shares owned by Wolverine Asset Management from 13F filings

Historical chart of Wolverine Asset Management investment in Mirum Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Mirum Pharmaceuticals held by Wolverine Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirum Pharmaceuticals by Wolverine Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $585k 20k 29.52
2023-09-30 $660k 21k 31.60
2023-06-30 $541k 21k 25.87

More positions owned by Wolverine Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Ati Note 3.500% 6/1 (Principal)
Zillow Group Note 1.375% 9/0 (Principal)
Cytokinetics Note 3.500% 7/0 (Principal)
Coinbase Global Com Cl A Put Option (COIN)
Amazon Call Option (AMZN)
Royal Caribbean Cruises Put Option (RCL)
Ascendis Pharma A/s Note 2.250% 4/0 (Principal)
NVIDIA Corporation Call Option (NVDA)
Li Auto Note 0.250% 5/0 (Principal)
Draftkings Note 3/1 (Principal)
Tesla Motors Call Option (TSLA)
Broadcom Call Option (AVGO)

View all positions for Wolverine Asset Management

Top funds holding Mirum Pharmaceuticals

Frazier Life Sciences Management
BVF
Eventide Asset Management
Vanguard Group
Henderson Group
Cadian Capital Management
Citadel Advisors
T. Rowe Price Associates
Avidity Partners Management
Tang Capital Management
Franklin Resources
First Turn Management
William Blair Investment Management
Perceptive Advisors
Boone Capital Management

View all funds holding Mirum Pharmaceuticals